chemistry.vc ↗Activity from announced rounds
Chemistry backs early-stage founders combining technical expertise with commercial insight.
Its approach emphasizes working with founders from the beginning. The firm’s official site distinguishes current Chemistry investments from investments its partners made before the firm, keeping those track records separate.
RoundOS records include Liquid Compute’s GPU-capacity marketplace and Wafer’s model-serving infrastructure. Assort Health, Fathom Therapeutics and Didero provide further examples in healthcare workflows, drug design and procurement software.
These examples describe financings recorded in RoundOS, rather than the investor’s complete portfolio.
Liquid Compute is building a market for GPU capacity that connects AI compute buyers, data centers, neoclouds and traders through a physical order book, standardized verification, clearing and settlement; it is onboarding participants while its planned derivatives exchange remains pending CFTC designation and registration.
Wafer runs AI inference infrastructure that adapts a model-serving stack to each customer's workload. It benchmarks and tunes models, engines, kernels and available hardware together, then keeps optimizing live serving for latency, reliability and cost as traffic changes.
Provides AI-powered patient journey platform for healthcare organizations
Uses quantum chemistry and AI to design novel drug molecules
Uses AI agents to automate enterprise procurement for manufacturers and distributors